Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Medtronic
AstraZeneca
Harvard Business School
Express Scripts

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Vadadustat

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Vadadustat: Sponsors, patents, clinical trial progress

Vadadustat is an investigational drug.

There have been 22 clinical trials for Vadadustat. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2016.

The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Kidney Diseases, and Anemia. The leading clinical trial sponsors are Akebia Therapeutics, Mitsubishi Tanabe Pharma Corporation, and [disabled in preview].

There are thirteen US patents protecting this investigational drug and one hundred and four international patents.

Recent Clinical Trials for Vadadustat
TitleSponsorPhase
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney DiseaseAkebia TherapeuticsPhase 1
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin AlfaAkebia TherapeuticsPhase 2
A Phase 1, Fixed Sequence, Open-label Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of VadadustatAkebia TherapeuticsPhase 1

See all Vadadustat clinical trials

Clinical Trial Summary for Vadadustat

Top disease conditions for Vadadustat
Top clinical trial sponsors for Vadadustat

See all Vadadustat clinical trials

US Patents for Vadadustat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Vadadustat   See Pricing Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof Akebia Therapeutics, Inc. (Cambridge, MA)   See Pricing
Vadadustat   See Pricing Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides Akebia Therapeutics, Inc. (Cambridge, MA)   See Pricing
Vadadustat   See Pricing Prolyl hydroxylase inhibitors and methods of use Warner Chilcott Company, LLC (Pajardo, PR)   See Pricing
Vadadustat   See Pricing Prolyl hydroxylase inhibitors and methods of use Akebia Therapeutics Inc. (Cincinnati, OH)   See Pricing
Vadadustat   See Pricing Prolyl hydroxylase inhibitors and methods of use Akebia Therapeutics Inc. (Cincinnati, OH)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Vadadustat

Drugname Country Document Number Estimated Expiration Related US Patent
Vadadustat Argentina 099354 2033-11-15   See Pricing
Vadadustat Australia 2014348523 2033-11-15   See Pricing
Vadadustat Australia 2019202144 2033-11-15   See Pricing
Vadadustat Canada 2930128 2033-11-15   See Pricing
Vadadustat Chile 2016001150 2033-11-15   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Express Scripts
Colorcon
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.